UDCA exposure among participants with cirrhosis tied to reduced odds of developing SARS-CoV-2 infection
Breakthrough SARS-CoV-2 Similar for Chronic Liver Disease With, Without Cirrhosis
However, full vaccination associated with two-thirds lower risk for death with cirrhosis
COVID-19 mRNA Vaccine Reduces Infections in Cirrhosis Patients
64.8 percent reduction in COVID-19 infections seen 28 days after receipt of first dose of mRNA vaccine